Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
The current price of BWAY is $13.58 USD — it has increased by +2.18% in the past 24 hours. Watch Brainsway stock price performance more closely on the chart.
What is Brainsway stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Brainsway stocks are traded under the ticker BWAY.
Is Brainsway stock price growing?▼
BWAY stock has risen by +0.67% compared to the previous week, the month change is a +14.65% rise, over the last year Brainsway has showed a +186.2% increase.
What were Brainsway earnings last quarter?▼
BWAY earnings for the last quarter are 0.05 USD per share, whereas the estimation was 0.05 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Brainsway revenue for the last year?▼
Brainsway revenue for the last year amounts to 41.02M USD.
What is Brainsway net income for the last year?▼
BWAY net income for the last year is 2.92M USD.
How many employees does Brainsway have?▼
As of April 02, 2026, the company has 120 employees.
In which sector is Brainsway located?▼
Brainsway operates in the Health Care sector.
When did Brainsway complete a stock split?▼
The last stock split for Brainsway was on March 03, 2026 with a ratio of 2:1.